Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Developing a Qualification and Verification Strategy for Digital Tissue Image Analysis in Toxicological Pathology.

PMID: 33371797 ·

A, l, e, k, s, a, n, d, r, a, , Z, u, r, a, w, ;, , M, i, c, h, a, e, l, , S, t, a, u, p, ;, , R, o, b, e, r, t, , K, l, o, p, f, l, e, i, s, c, h, ;, , F, a, m, k, e, , A, e, f, f, n, e, r, ;, , D, a, n, i, e, l, l, e, , B, r, o, w, n, ;, , T, h, o, m, a, s, , W, e, s, t, e, r, l, i, n, g, -, B, u, i, ;, , D, a, n, i, e, l, , R, u, d, m, a, n, n

RevistaToxicologic pathology
Año
PMID33371797

Resumen

Digital tissue image analysis is a computational method for analyzing whole-slide images and extracting large, complex, and quantitative data sets. However, as with any analysis method, the quality of generated results is dependent on a well-designed quality control system for the entire digital pathology workflow. Such system requires clear procedural controls, appropriate user training, and involvement of specialists to oversee key steps of the workflow. The toxicologic pathologist is responsi

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑